Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Details Narrative)

v3.5.0.2
Equity Transactions (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 04, 2016
Jan. 28, 2016
Dec. 01, 2015
Oct. 30, 2015
Mar. 21, 2015
Nov. 12, 2014
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Exercise price of common stock granted                 $ 0.09  
Number of common stock shares issued for service                 3,811,667  
Share based compensation             $ 115,874 $ 476,732 $ 347,763 $ 914,505
Unrecognized stock based compensation expense             $ 1,261,402   $ 1,261,402  
Warrants granted to purchase of common stock shares             16,449,734   16,449,734  
Vendor [Member]                    
Number of common stock shares issued for service             1,411,667   3,811,667  
Share based compensation             $ 217,403   $ 475,608
Board of Directors [Member]                    
Number of common stock shares issued for service             750,000   1,150,000  
Share based compensation             $ 97,500   $ 321,682  
Stock Subscription to Investors [Member]                    
Number of common stock shares issued, shares             11,713,334   32,135,556  
Number of common stock shares issued, Value             $ 545,850   $ 1,464,850  
Chief Executive Officer and Board of Director [Member]                    
Warrants granted to purchase of common stock shares 2,452,325                  
Warrant exercise price per share $ 0.07                  
Secured convertible note issued $ 343,326                  
Interest rate 12.00%                  
Debt conversion percentage of amount 30.00%                  
Warrants percentage 50.00%                  
Oceanside Strategies, Inc [Member]                    
Number of common stock price per share $ 0.07                  
Warrants granted to purchase of common stock shares 2,429,530                  
Warrant exercise price per share $ 0.07                  
Maturity date Dec. 04, 2016                  
Interest rate 12.00%                  
Debt conversion percentage of amount 30.00%                  
Unsecured convertible note payable $ 680,268                  
Employees [Member]                    
Number of restricted common stock shares issued during the period   9,011,324                
Exercise price of common stock granted   $ 0.02                
Share repurchases   8,311,324                
Number of common stock shares repurchase during the period             166,226   166,226  
Consultant [Member]                    
Warrants granted to purchase of common stock shares       600,000   600,000        
Warrant exercise price per share       $ 0.50   $ 0.50        
Warrants expire date       Oct. 30, 2020   Nov. 12, 2019        
DelMorgan [Member]                    
Unrecognized stock based compensation expense         $ 20,114          
Warrants granted to purchase of common stock shares         48,000          
Warrant exercise price per share         $ 0.10          
Warrants expire date         Mar. 20, 2018          
Chief Executive Officer and Board of Director [Member]                    
Warrant exercise price per share     $ 0.07              
Number of warrants granted for consideration of extend the payment terms of note payables     9,719,879              
Maturity date     Apr. 01, 2017